A mother’s demand for accountability after her daughter’s sudden epilepsy death has put renewed attention on how doctors explain risk, follow-up and emergency planning to families. Jo-Ann Burns has described the shock of losing Nicola after what seemed like an ordinary night, a story that many epilepsy families recognize with dread. By March 24, 2026, the case had become part of a wider conversation about sudden unexpected death in epilepsy and whether patients are being warned clearly enough.
Sudden unexpected death in epilepsy, often shortened to SUDEP, is rare but devastating. It can occur when a person with epilepsy dies without another clear cause, often during or after a seizure. The rarity creates a communication problem: clinicians do not want to terrify families, but silence can leave them unprepared.
Risk Is Hard to Discuss but Necessary
Good epilepsy care requires more than medication adjustments. Patients and relatives need to understand seizure patterns, missed-dose risks, sleep disruption, alcohol interactions and when to seek urgent help. None of that guarantees prevention, but it gives families a clearer role in reducing risk. SUDEP awareness has improved, yet families still report uneven conversations. Some are told directly. Others learn about the risk only after a death or through their own research. That inconsistency is exactly what accountability campaigns are trying to change.
Follow-Up Can Decide Whether Warnings Stick
A single warning in a clinic is not enough. People absorb information differently, especially when they are already managing a chronic condition. Written plans, repeated conversations and clear escalation steps can help families remember what matters when daily life becomes busy. Clinicians also need time, and many health systems do not give them enough of it. Short appointments can prioritize prescriptions and test results while leaving risk counseling unfinished. That is a system problem, not only an individual failure.
Families Need Practical Tools
Practical support can include seizure action plans, medication reminders, sleep guidance, rescue-medication instructions and advice about nighttime monitoring for higher-risk patients. Not every tool fits every person. The point is to make risk reduction specific rather than vague. Bereaved families often ask whether a different conversation would have changed the outcome. Medicine cannot answer that question with certainty in every case. It can answer by making sure future families receive clearer information before a crisis. The demand for accountability should therefore be read as a demand for better communication. Families are not asking clinicians to eliminate all risk. They are asking to be trusted with the truth early enough to act on it.
Risk discussions also need to be individualized. A patient with frequent tonic-clonic seizures, missed medication doses or nighttime seizures may face a different risk profile from someone whose epilepsy is well controlled. Families need to know which factors apply to them rather than receiving a generic warning. Technology can help, but it is not a complete answer. Seizure monitors, wearable devices and nighttime alarms may provide reassurance for some families, yet false alarms and missed events remain concerns. Clinicians should present tools honestly instead of treating them as guarantees. Mental health support is part of the picture too. Living with epilepsy can create anxiety, sleep disruption and social isolation. Families navigating risk need counseling that recognizes the emotional load, not only the neurological diagnosis.
After a sudden death, accountability reviews should examine records, communication and follow-up systems. The goal is not to assign blame before facts are known. It is to identify whether a warning was missed, a care plan was unclear or a family was left without practical guidance. Public campaigns by bereaved parents can be uncomfortable for institutions, but they often force improvements that routine audits do not. They bring urgency to risks that medical systems may understand statistically but fail to communicate humanely. The clearest reform is consistency. Every epilepsy patient and family should know whether SUDEP is relevant to their situation, what steps can reduce risk and who to contact when seizure patterns change.
Schools, employers and caregivers may also need clearer guidance. Epilepsy risk does not stay inside the clinic. A person may have seizures at work, in shared housing or while traveling, and people nearby often do not know what to do beyond calling emergency services. Better communication can reduce stigma as well as danger. When families understand risk in practical terms, epilepsy is less likely to be treated as either harmless or terrifying. The goal is a middle ground: honest enough to protect people, calm enough to support ordinary life.
Primary care doctors also need a role because many patients do not see epilepsy specialists often. If routine appointments include seizure-control questions and reminders about emergency plans, risk communication becomes less dependent on rare specialist visits. That kind of shared-care model can make safety advice more consistent across the health system. That consistency would not remove grief from every case, but it would reduce the number of families left wondering what they were never told. Families deserve that clarity before tragedy, not only after it becomes a campaign. That is a modest standard, but it would change care for many families.
That distinction matters because families, doctors and public-health groups need the same practical target: fewer preventable deaths and clearer warnings before risk becomes tragedy.